ZYDUSLIFENSEZydus Lifesciences LimitedHighPositive
Announced Tue, 19 May · 14:25 IST

Zydus Lifesciences Limited has informed the Exchange that Record date for the purpose of Buyback is 29-May-2026.

Corporate Actions View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.9%1-day move
₹992.00
prior close
₹1043.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5+0.1-0.3-1.8+4.9+4.5+4.7+8.0+8.6+9.1+10.6+8.1+15.8
Up moveDown movePending
AI summary

Zydus Lifesciences Limited's Board has approved a buyback of up to 95,65,217 fully paid-up equity shares (0.95% of total paid-up capital) at INR 1,150 per share. The maximum buyback size is INR 1,100 crore, representing 5.16% and 3.84% of the company's fully paid-up equity share capital and free reserves on standalone and consolidated basis respectively as of March 31, 2026. The buyback will be conducted through the tender offer route, open to all equity shareholders including promoters on a proportionate basis. The record date for determining eligible shareholders is May 29, 2026. Promoters currently hold approximately 75% of the company shares.

Likely market impact

Shareholders get an opportunity to tender shares at INR 1,150 each, providing liquidity and potential gains if the buyback price is above market. However, the impact is limited given only 0.95% of shares are being bought back.